(Reuters) - The Food and Drug Administration has added Pfizer Inc's tuberculosis treatment rifampin to its list of drugs in short supply, the latest in a growing number of spottily available TB ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

ATLANTA, Jan 17 (Reuters) - More than 80 percent of health departments in the United States that treat tuberculosis resistant to standard treatment have trouble obtaining the drugs they need to cure ...

Researchers at IIT Bombay and Monash University have discovered that tuberculosis bacteria resist antibiotics by altering ...

Scientists have uncovered why tuberculosis bacteria evade antibiotics by entering a dormant state. Researchers found that ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

The Union World Conference on Lung Health showcased a study on preventive therapy pills and a potential new TB drug, ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Cases of tuberculosis are rising in the UK and US, and experts are urging that a holistic approach to treatment is the best ...

CHICAGO -- New research gives hope for successfully treating tuberculosis in a few months rather than the six months or more currently needed to beat the contagious lung disease, doctors reported ...